{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:42:54Z","timestamp":1776087774888,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071921"],"award-info":[{"award-number":["82071921"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04720-w","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:54:40Z","timestamp":1772765680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a model incorporating choroid plexus morphology from brain MRI to predict anti-TNF-\u03b1 therapy outcomes in Crohn\u2019s disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengting","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heshui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4720_CR1","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2012-303955","volume":"62","author":"MZ Cader","year":"2013","unstructured":"Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut. 2013;62:1653\u201364.","journal-title":"Gut"},{"key":"4720_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, et al. Crohn\u2019s disease. Nat Rev Dis Primers. 2020;6:22.","journal-title":"Nat Rev Dis Primers"},{"key":"4720_CR3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"4720_CR4","doi-asserted-by":"publisher","unstructured":"Boronat-Toscano A, Monfort-Ferr\u00e9 D, Menacho M et al. Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn\u2019s Disease. Int J Mol Sci. 2022;23(19):11170. https:\/\/doi.org\/10.3390\/ijms231911170","DOI":"10.3390\/ijms231911170"},{"key":"4720_CR5","doi-asserted-by":"publisher","unstructured":"Gisbert JP, Chaparro M. Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)? J Clin Med. 2021;10(22):5318. https:\/\/doi.org\/10.3390\/jcm10225318","DOI":"10.3390\/jcm10225318"},{"key":"4720_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","volume":"4","author":"NA Kennedy","year":"2019","unstructured":"Kennedy NA, Heap GA, Green HD, et al. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2019;4:341\u201353.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4720_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/1751-7915.13536","volume":"13","author":"L Xiang","year":"2020","unstructured":"Xiang L, Ding X, Li Q, et al. Efficacy of faecal microbiota transplantation in Crohn\u2019s disease: a new target treatment? Microb Biotechnol. 2020;13:760\u20139.","journal-title":"Microb Biotechnol"},{"key":"4720_CR8","doi-asserted-by":"publisher","unstructured":"Orfanoudaki E, Foteinogiannopoulou K, Theodoraki E et al. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease. J Clin Med. 2023;12(7):2452. https:\/\/doi.org\/10.3390\/jcm12072452","DOI":"10.3390\/jcm12072452"},{"key":"4720_CR9","doi-asserted-by":"publisher","first-page":"103329","DOI":"10.1016\/j.ebiom.2021.103329","volume":"66","author":"G Cui","year":"2021","unstructured":"Cui G, Fan Q, Li Z, et al. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine. 2021;66:103329.","journal-title":"EBioMedicine"},{"key":"4720_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","volume":"14","author":"JP Gisbert","year":"2020","unstructured":"Gisbert JP, Chaparro M. Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice. J Crohns Colitis. 2020;14:694\u2013709.","journal-title":"J Crohns Colitis"},{"key":"4720_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000511641","volume":"39","author":"G Dragoni","year":"2021","unstructured":"Dragoni G, Innocenti T, Galli A. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches? Dig Dis. 2021;39:190\u2013203.","journal-title":"Dig Dis"},{"key":"4720_CR12","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1053\/j.gastro.2018.01.027","volume":"154","author":"DJ Gracie","year":"2018","unstructured":"Gracie DJ, Guthrie EA, Hamlin PJ, et al. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology. 2018;154:1635\u2013e16463.","journal-title":"Gastroenterology"},{"key":"4720_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-019-0259-y","volume":"17","author":"A Mikocka-Walus","year":"2020","unstructured":"Mikocka-Walus A, Ford AC, Drossman DA. Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17:184\u201392.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4720_CR14","doi-asserted-by":"publisher","first-page":"E2960","DOI":"10.1073\/pnas.1720696115","volume":"115","author":"X Gao","year":"2018","unstructured":"Gao X, Cao Q, Cheng Y, et al. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proc Natl Acad Sci U S A. 2018;115:E2960\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4720_CR15","doi-asserted-by":"publisher","first-page":"1016578","DOI":"10.3389\/fimmu.2022.1016578","volume":"13","author":"L Ge","year":"2022","unstructured":"Ge L, Liu S, Li S, et al. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut-brain communications. Front Immunol. 2022;13:1016578.","journal-title":"Front Immunol"},{"key":"4720_CR16","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1177\/0271678X19872563","volume":"40","author":"SE Johnson","year":"2020","unstructured":"Johnson SE, McKnight CD, Lants SK, et al. Choroid plexus perfusion and intracranial cerebrospinal fluid changes after angiogenesis. J Cereb Blood Flow Metab. 2020;40:1658\u201371.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4720_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrn3921","volume":"16","author":"MP Lun","year":"2015","unstructured":"Lun MP, Monuki ES, Lehtinen MK. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci. 2015;16:445\u201357.","journal-title":"Nat Rev Neurosci"},{"key":"4720_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/science.abc6108","volume":"374","author":"S Carloni","year":"2021","unstructured":"Carloni S, Bertocchi A, Mancinelli S, et al. Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science. 2021;374:439\u201348.","journal-title":"Science"},{"key":"4720_CR19","doi-asserted-by":"publisher","first-page":"C855","DOI":"10.1152\/ajpcell.00470.2006","volume":"293","author":"P Zeni","year":"2007","unstructured":"Zeni P, Doepker E, Schulze-Topphoff U, et al. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro. Am J Physiol Cell Physiol. 2007;293:C855\u201364.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4720_CR20","doi-asserted-by":"publisher","first-page":"106416","DOI":"10.1016\/j.nbd.2024.106416","volume":"192","author":"C Bonifacio","year":"2024","unstructured":"Bonifacio C, Savini G, Reca C, et al. The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn\u2019s disease. Neurobiol Dis. 2024;192:106416.","journal-title":"Neurobiol Dis"},{"key":"4720_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144\u201364.","journal-title":"J Crohns Colitis"},{"key":"4720_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u201344.","journal-title":"Gastroenterology"},{"key":"4720_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","volume":"106","author":"EJ Irvine","year":"1994","unstructured":"Irvine EJ, Feagan B, Rochon J, Canadian Crohn\u2019s Relapse Prevention Trial Study Group. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994;106:287\u201396.","journal-title":"Gastroenterology"},{"key":"4720_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12876-020-1166-y","volume":"20","author":"H Fu","year":"2020","unstructured":"Fu H, Kaminga AC, Peng Y, et al. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms. BMC Gastroenterol. 2020;20:11.","journal-title":"BMC Gastroenterol"},{"key":"4720_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1008931926181","volume":"9","author":"N Schmitz","year":"2000","unstructured":"Schmitz N, Hartkamp N, Kiuse J, et al. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual Life Res. 2000;9:185\u201393.","journal-title":"Qual Life Res"},{"key":"4720_CR26","doi-asserted-by":"publisher","first-page":"e27446","DOI":"10.1016\/j.heliyon.2024.e27446","volume":"10","author":"M Huang","year":"2024","unstructured":"Huang M, Ma H, Zou Y, et al. Structural alterations of brain in different disease states of Crohn\u2019s disease: Results of a cross-sectional study in a Chinese hospital. Heliyon. 2024;10:e27446.","journal-title":"Heliyon"},{"key":"4720_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11682-022-00742-6","volume":"17","author":"G Thapaliya","year":"2023","unstructured":"Thapaliya G, Eldeghaidy S, Asghar M, et al. The relationship between Central Nervous System morphometry changes and key symptoms in Crohn\u2019s disease. Brain Imaging Behav. 2023;17:149\u201360.","journal-title":"Brain Imaging Behav"},{"key":"4720_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41575-020-0352-2","volume":"17","author":"M Argollo","year":"2020","unstructured":"Argollo M, Kotze PG, Kakkadasam P, et al. Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? Nat Rev Gastroenterol Hepatol. 2020;17:702\u201310.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4720_CR29","doi-asserted-by":"publisher","unstructured":"Wong R, Qin L, Pan Y et al. Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease. J Clin Med. 2023;12(21):6796. https:\/\/doi.org\/10.3390\/jcm12216796","DOI":"10.3390\/jcm12216796"},{"key":"4720_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1080\/00365521.2020.1786852","volume":"55","author":"S Buhl","year":"2020","unstructured":"Buhl S, Dorn-Rasmussen M, Brynskov J, et al. Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease. Scand J Gastroenterol. 2020;55:884\u201390.","journal-title":"Scand J Gastroenterol"},{"key":"4720_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/7854_2016_37","volume":"31","author":"C D\u2019Mello","year":"2017","unstructured":"D\u2019Mello C, Swain MG. Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression. Curr Top Behav Neurosci. 2017;31:73\u201394.","journal-title":"Curr Top Behav Neurosci"},{"key":"4720_CR32","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1002\/hbm.26439","volume":"44","author":"J Wang","year":"2023","unstructured":"Wang J, Liu G, Xu K, et al. The role of neurotransmitters in mediating the relationship between brain alterations and depressive symptoms in patients with inflammatory bowel disease. Hum Brain Mapp. 2023;44:5357\u201371.","journal-title":"Hum Brain Mapp"},{"key":"4720_CR33","doi-asserted-by":"publisher","first-page":"1361320","DOI":"10.3389\/fnins.2024.1361320","volume":"18","author":"M Huang","year":"2024","unstructured":"Huang M, Ma G, Zou Y, et al. A potential brain functional biomarker distinguishing patients with Crohn\u2019s disease with different disease stages: a resting-state fMRI study. Front Neurosci. 2024;18:1361320.","journal-title":"Front Neurosci"},{"key":"4720_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, et al. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:267.","journal-title":"Signal Transduct Target Ther"},{"key":"4720_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1148\/radiol.212400","volume":"304","author":"JD Choi","year":"2022","unstructured":"Choi JD, Moon Y, Kim HJ, et al. Choroid Plexus Volume and Permeability at Brain MRI within the Alzheimer Disease Clinical Spectrum. Radiology. 2022;304:635\u201345.","journal-title":"Radiology"},{"key":"4720_CR36","doi-asserted-by":"publisher","first-page":"175628482412562","DOI":"10.1177\/17562848241256237","volume":"17","author":"L Chen","year":"2024","unstructured":"Chen L, Kang D, Fang L, et al. Development and validation of a novel therapeutic drug monitoring-based nomogram for prediction of primary endoscopic response to anti-TNF therapy in active Crohn\u2019s disease. Th Adv Gastroenterol. 2024;17:17562848241256237.","journal-title":"Th Adv Gastroenterol"},{"key":"4720_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13244-021-01083-6","volume":"12","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Xiong Z, Xie Q, et al. Computed tomography-based multiple body composition parameters predict outcomes in Crohn\u2019s disease. Insights Imaging. 2021;12:135.","journal-title":"Insights Imaging"},{"key":"4720_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5009\/gnl20322","volume":"16","author":"ES Kim","year":"2022","unstructured":"Kim ES, Kwon Y, Choe YH, et al. Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor \u03b1 Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn\u2019s Disease Patients. Gut Liver. 2022;16:71\u201380.","journal-title":"Gut Liver"},{"key":"4720_CR39","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.cgh.2020.02.010","volume":"18","author":"PS Dulai","year":"2020","unstructured":"Dulai PS, Singh S, Vande Casteele N, et al. Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020;18:2952\u2013e29618.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4720_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12967-024-05058-1","volume":"22","author":"M Kumar","year":"2024","unstructured":"Kumar M, Murugesan S, Ibrahim N, et al. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. J Transl Med. 2024;22:284.","journal-title":"J Transl Med"},{"key":"4720_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/ibd\/izaa088","volume":"27","author":"RK Grant","year":"2021","unstructured":"Grant RK, Jones GR, Plevris N, et al. The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis. Inflamm Bowel Dis. 2021;27:451\u20137.","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04720-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:42:33Z","timestamp":1776084153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04720-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4720"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04720-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics committee of Union Hospital of Tongji Medical College of Huazhong University of Science and Technology (0940-01). All participants were signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}